Dmitriy Zamarin is the Section Head of Gynecologic Medical Oncology, a member of the Icahn Genomics Institute and the Precision Immunology Institute at the Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai and the Principal Investigator of the Zamarin Lab. He has spent a decade as a faculty and Translational Research Director in Gynecologic Medical Oncology at the Memorial Sloan Kettering Cancer Center before transitioning to his current role in September of 2023. His research is focused on understanding of the mechanisms by which gynecologic cancers are recognized by the immune system and on identification of biomarkers predictive of response and resistance to immunotherapy. To learn more about Dr. Zamarin and his work, please visit our “About Us” page.

Mahima graduated with a PhD in Biomedical Science from the University of Nebraska-Lincoln in 2024. She hails from Mangalore, India.

Meet Sandhya, a graduate student in the Zamarin lab. She earned her Bachelor’s and Master’s degrees in Biotechnology in India, where her love for science began. Before diving into her PhD, she worked as a research tech on projects developing therapeutic platforms for glioblastoma multiforme, including radiotherapy and GD2 CAR-T cell therapy. Sandhya’s interest for creating innovative cancer immunotherapies brought her to the lab, where she’s now exploring virotherapy. Outside the lab, you might find her taking long walks around the city, petting dogs and hunting down the best new eats.

Konrad is a second-year PhD student in Cancer Biology. He completed his bachelor’s degree at the University of Wroclaw and then pursued a master’s degree at the University of Warsaw in collaboration with the Mossakowski Medical Research Institute, Polish Academy of Sciences. After earning his master’s, Konrad moved to Boston, where he worked for two years as a Research Assistant at the Dana-Farber Cancer Institute | Harvard Medical School. In June, Konrad joined the Zamarin Lab, where he focuses on endometrial cancer research. In his free time, Konrad dedicates himself to photography and enjoys exploring NYC.

Eric Craig is a Gynecologic Oncology Fellow originally from Blue Ridge, GA. He completed his undergraduate education at the University of North Georgia where he graduated with honors and received a B.S. in Biology. He then attended medical school at the University of Alabama at Birmingham where he received his M.D.  He was awarded membership in the honor societies of Alpha Omega Alpha and the Gold Humanism Society, as well as the HPSP Scholarship from the US Navy. He went on to complete his Gynecologic Surgery and Obstetrics Residency training at Walter Reed National Military Medical Center.  Following graduation, he spent 4 years as an attending physician in the Navy, and was stationed at Marine Corps Air Station Iwakuni, Japan followed by a tour at Navy Medical Center San Diego. He deployed in support of Pacific Partnership 2022 on the USNS Mercy hospital ship. He recently separated from active-duty military service to pursue fellowship training in gynecologic oncology, which has been his career goal all along. His prior research experience includes database reviews and reports on racial disparities in gynecologic cancer outcomes as well as clinical trials investigating postoperative pain management strategies. His current research interests focus on the immune system’s role in cancer outcomes and the effects that metabolic derangements have on the immune system in cancer patients.

TBD!

Melih Arda Ozsoy was an Associate Researcher from Bursa, Turkey. He has graduated from Brown University with honors in Biochemistry and Molecular Biology in 2022, and since then, has been working under the guidance of Dr. Zamarin. During his time in college, Melih Arda wrote his senior’s thesis on immunologic signatures to front-line therapy in high grade serous ovarian cancer to better understand and ameliorate chemoresistance, for which he received The Llealyn B. Clapp Prize for Outstanding Undergraduate Thesis. His research in the Zamarin Lab was on the use of oncolytic viruses for the treatment of various gynecological malignancies, with a specific focus on ovarian and endometrial cancers. He is currently a Ph.D. candidate of Microbiology and Immunology at Columbia University Irving Medical Center.

Money Gupta was an Associate Computational Scientist in our lab. She completed her Ph.D in pathology from University of New South Wales, Sydney in 2022. She has worked extensively in the areas of adaptive immune responses against Hepatitis C virus and Covid-19 looking at their T and B cell responses.